1. Home
  2. XENE vs FUL Comparison

XENE vs FUL Comparison

Compare XENE & FUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • FUL
  • Stock Information
  • Founded
  • XENE 1996
  • FUL 1887
  • Country
  • XENE Canada
  • FUL United States
  • Employees
  • XENE N/A
  • FUL N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • FUL Home Furnishings
  • Sector
  • XENE Health Care
  • FUL Industrials
  • Exchange
  • XENE Nasdaq
  • FUL Nasdaq
  • Market Cap
  • XENE 3.3B
  • FUL 3.7B
  • IPO Year
  • XENE 2014
  • FUL N/A
  • Fundamental
  • Price
  • XENE $38.52
  • FUL $62.09
  • Analyst Decision
  • XENE Strong Buy
  • FUL Buy
  • Analyst Count
  • XENE 7
  • FUL 5
  • Target Price
  • XENE $56.00
  • FUL $84.20
  • AVG Volume (30 Days)
  • XENE 424.9K
  • FUL 439.7K
  • Earning Date
  • XENE 02-27-2025
  • FUL 01-15-2025
  • Dividend Yield
  • XENE N/A
  • FUL 1.44%
  • EPS Growth
  • XENE N/A
  • FUL N/A
  • EPS
  • XENE N/A
  • FUL 2.30
  • Revenue
  • XENE N/A
  • FUL $3,568,736,000.00
  • Revenue This Year
  • XENE N/A
  • FUL $2.48
  • Revenue Next Year
  • XENE $1,600.08
  • FUL $0.89
  • P/E Ratio
  • XENE N/A
  • FUL $27.00
  • Revenue Growth
  • XENE N/A
  • FUL 1.65
  • 52 Week Low
  • XENE $35.53
  • FUL $60.96
  • 52 Week High
  • XENE $50.99
  • FUL $87.67
  • Technical
  • Relative Strength Index (RSI)
  • XENE 42.98
  • FUL 30.59
  • Support Level
  • XENE $36.90
  • FUL $61.45
  • Resistance Level
  • XENE $41.03
  • FUL $65.36
  • Average True Range (ATR)
  • XENE 1.41
  • FUL 1.75
  • MACD
  • XENE 0.03
  • FUL 0.07
  • Stochastic Oscillator
  • XENE 30.39
  • FUL 14.00

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

About FUL H. B. Fuller Company

H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.

Share on Social Networks: